Gary E. Stein

3.5k total citations
82 papers, 2.6k citations indexed

About

Gary E. Stein is a scholar working on Pharmacology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Gary E. Stein has authored 82 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Pharmacology, 40 papers in Epidemiology and 34 papers in Infectious Diseases. Recurrent topics in Gary E. Stein's work include Antibiotics Pharmacokinetics and Efficacy (47 papers), Antimicrobial Resistance in Staphylococcus (25 papers) and Antibiotic Resistance in Bacteria (21 papers). Gary E. Stein is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (47 papers), Antimicrobial Resistance in Staphylococcus (25 papers) and Antibiotic Resistance in Bacteria (21 papers). Gary E. Stein collaborates with scholars based in United States, Australia and Switzerland. Gary E. Stein's co-authors include Louis D. Saravolatz, Timothy Babinchak, Leonard B. Johnson, Daniel Havlichek, Elizabeth Wells, David P. Nicolau, Robert D. Walker, Thomas M. File, E. J. C. Goldstein and J. G. Hauptman and has published in prestigious journals such as Clinical Infectious Diseases, The American Journal of Medicine and Journal of Clinical Microbiology.

In The Last Decade

Gary E. Stein

81 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary E. Stein United States 30 933 909 864 743 429 82 2.6k
Dwight J. Hardy United States 27 1.2k 1.3× 674 0.7× 825 1.0× 721 1.0× 327 0.8× 89 3.0k
Andrea Novelli Italy 34 1.2k 1.3× 1.3k 1.5× 950 1.1× 744 1.0× 421 1.0× 166 3.7k
Joseph M. Blondeau Canada 28 1.1k 1.2× 1.2k 1.3× 682 0.8× 1.1k 1.4× 552 1.3× 136 3.4k
Inga Odenholt Sweden 29 838 0.9× 729 0.8× 673 0.8× 821 1.1× 280 0.7× 73 2.4k
Michael L. Corrado United States 26 1.4k 1.5× 835 0.9× 933 1.1× 526 0.7× 237 0.6× 65 2.7k
C Carbon France 35 1.5k 1.6× 1.2k 1.4× 1.3k 1.5× 765 1.0× 615 1.4× 161 3.4k
Mark E. Jones United States 29 1.8k 2.0× 882 1.0× 905 1.0× 985 1.3× 517 1.2× 73 3.2k
L. Verbist Belgium 29 1.0k 1.1× 1.1k 1.2× 894 1.0× 686 0.9× 323 0.8× 127 2.7k
Hiroshige Mikamo Japan 28 1.1k 1.2× 629 0.7× 1.3k 1.5× 466 0.6× 447 1.0× 235 2.9k
Claude Carbón France 27 1.1k 1.2× 699 0.8× 735 0.9× 498 0.7× 290 0.7× 91 2.6k

Countries citing papers authored by Gary E. Stein

Since Specialization
Citations

This map shows the geographic impact of Gary E. Stein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary E. Stein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary E. Stein more than expected).

Fields of papers citing papers by Gary E. Stein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary E. Stein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary E. Stein. The network helps show where Gary E. Stein may publish in the future.

Co-authorship network of co-authors of Gary E. Stein

This figure shows the co-authorship network connecting the top 25 collaborators of Gary E. Stein. A scholar is included among the top collaborators of Gary E. Stein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary E. Stein. Gary E. Stein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cooper, Christopher, et al.. (2021). Long-Acting Lipoglycopeptides for the Treatment of Bone and Joint Infections. Surgical Infections. 22(8). 771–779. 5 indexed citations
2.
Stein, Gary E., Curtis Smith, James M. Kidd, et al.. (2018). Pharmacokinetic and Pharmacodynamic Analysis of Ceftazidime/Avibactam in Critically Ill Patients. Surgical Infections. 20(1). 55–61. 43 indexed citations
3.
Stein, Gary E., et al.. (2015). A Pharmacokinetic/Pharmacodynamic Analysis of Ceftaroline Prophylaxis in Patients with External Ventricular Drains. Surgical Infections. 16(2). 169–173. 13 indexed citations
4.
Stein, Gary E. & Timothy Babinchak. (2013). Tigecycline: an update. Diagnostic Microbiology and Infectious Disease. 75(4). 331–336. 150 indexed citations
5.
File, Thomas M., Mark H. Wilcox, & Gary E. Stein. (2012). Summary of Ceftaroline Fosamil Clinical Trial Studies and Clinical Safety. Clinical Infectious Diseases. 55(suppl_3). S173–S180. 80 indexed citations
6.
Stein, Gary E., et al.. (2011). Tigecycline Penetration into Skin and Soft Tissue. Surgical Infections. 12(6). 465–467. 15 indexed citations
7.
Saravolatz, Louis D., Gary E. Stein, & Leonard B. Johnson. (2011). Ceftaroline: A Novel Cephalosporin with Activity against Methicillin-resistant Staphylococcus aureus. Clinical Infectious Diseases. 52(9). 1156–1163. 127 indexed citations
8.
Nicolau, David P. & Gary E. Stein. (2010). Therapeutic Options for Diabetic Foot Infections. Journal of the American Podiatric Medical Association. 100(1). 52–63. 35 indexed citations
9.
Saravolatz, Louis D., Gary E. Stein, & Leonard B. Johnson. (2009). Telavancin: A Novel Lipoglycopeptide. Clinical Infectious Diseases. 49(12). 1908–1914. 87 indexed citations
10.
Stein, Gary E. & E. J. C. Goldstein. (2006). Fluoroquinolones and Anaerobes. Clinical Infectious Diseases. 42(11). 1598–1607. 58 indexed citations
11.
Stein, Gary E., et al.. (2006). Tigecycline: A Critical Analysis. Clinical Infectious Diseases. 43(4). 518–524. 214 indexed citations
12.
13.
Stein, Gary E., et al.. (1998). Urinary Pharmacodynamics of Low-Dose Ciprofloxacin and Ofloxacin. Diagnostic Microbiology and Infectious Disease. 30(4). 261–265. 3 indexed citations
14.
Stein, Gary E., et al.. (1997). Pharmacodynamic Activity of Five Oral Cephalosporins Against Haemophilus influenzae. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 17(2). 235–241. 4 indexed citations
15.
Stein, Gary E., et al.. (1996). Prevention of Recurrent Vaginal Candidiasis with Weekly Terconazole Cream. Annals of Pharmacotherapy. 30(10). 1080–1083. 12 indexed citations
16.
Walker, Robert D., et al.. (1995). Pharmacokinetics, nephrotoxicosis, and in vitro antibacterial activity associated with single versus multiple (three times) daily gentamicin treatments in horses. American Journal of Veterinary Research. 56(5). 613–618. 38 indexed citations
17.
Stein, Gary E.. (1995). Safety Evaluation of a New Formulation of Intravenous Ofloxacin. Drugs. 49(Supplement 2). 497–498.
18.
Stein, Gary E., et al.. (1991). Use of rDNA restriction fragment length polymorphisms to differentiate strains of Candida albicans in women with vulvovaginal candidiasis. Diagnostic Microbiology and Infectious Disease. 14(6). 459–464. 23 indexed citations
19.
Walker, Robert D., et al.. (1990). Serum and tissue cage fluid concentrations of ciprofloxacin after oral administration of the drug to healthy dogs. American Journal of Veterinary Research. 51(6). 896–900. 35 indexed citations
20.
Stein, Gary E.. (1988). The 4‐Quinolone Antibiotics: Past, Present, and Future. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 8(6). 301–314. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dwight J. Hardy Breakdown of academic impact, for papers by Andrea Novelli Breakdown of academic impact, for papers by Joseph M. Blondeau Breakdown of academic impact, for papers by Inga Odenholt Breakdown of academic impact, for papers by Michael L. Corrado Breakdown of academic impact, for papers by C Carbon Breakdown of academic impact, for papers by Mark E. Jones Breakdown of academic impact, for papers by L. Verbist Breakdown of academic impact, for papers by Hiroshige Mikamo Breakdown of academic impact, for papers by Claude Carbón
Rankless by CCL
2026